Cranford Pharmaceuticals - Inderal XL's Unit Acquisition

Cranford Pharmaceuticals - Inderal XL raised a round of funding on February 24, 2017. Investors include ANI Pharmaceuticals.

Cranford Pharmaceuticals is based out of Cranford, New Jersey, and manufactures specialty pharmaceutical products. Inderal XL is a beta adrenergic blocker indicated for the treatment of hypertension, …

Articles about Cranford Pharmaceuticals - Inderal XL's Unit Acquisition: